Neuroinflammation in Parkinson's disease and related disorders: A lesson from genetically manipulated mouse models of α-synucleinopathies

Parkinson's Disease

Volumn , Issue , 2012, Pages

  Sekiyama, Kazunari ^a   Sugama, Shuei ^b   Fujita, Masayo ^a   Sekigawa, Akio ^a   Takamatsu, Yoshiki ^a   Waragai, Masaaki ^a   Takenouchi, Takato ^c   Hashimoto, Makoto ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ASTROCYTE; BRAIN; DEGENERATIVE DISEASE; DISEASE COURSE; GENETIC MANIPULATION; GLIA CELL; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROGLIA; MEMORY DISORDER; MOUSE; NERVE CELL; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

EID: 84859761962     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.1155/2012/271732     Document Type: Review

References (57)

1. Hashimoto M., Masliah E., -Synuclein in Lewy body disease and Alzheimer's disease Brain Pathology 1999 9 4 707 720 (Pubitemid 29470963)
2. Trojanowski J. Q., Goedert M., Iwatsubo T., Lee V. M. Y., Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia Cell Death and Differentiation 1998 5 10 832 837 (Pubitemid 28484393)
3. Rochet J. C., Lansbury P. T. Jr. , Amyloid fibrillogenesis: themes and variations Current Opinion in Structural Biology 2000 10 1 60 68 (Pubitemid 30099328)
4. Beyer K., Domingo-Sabat M., Ariza A., Molecular pathology of lewy body diseases International Journal of Molecular Sciences 2009 10 3 724 745
5. Block M. L., Zecca L., Hong J. S., Microglia-mediated neurotoxicity: uncovering the molecular mechanisms Nature Reviews Neuroscience 2007 8 1 57 69 (Pubitemid 46011999)
6. Kim Y. S., Joh T. H., Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease Experimental and Molecular Medicine 2006 38 4 333 347
7. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., Kawaguchi T., Tsunoda T., Watanabe M., Takeda A., Tomiyama H., Nakashima K., Hasegawa K., Obata F., Yoshikawa T., Kawakami H., Sakoda S., Yamamoto M., Hattori N., Murata M., Nakamura Y., Toda T., Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease Nature Genetics 2009 41 12 1303 1307
8. Simon-Sanchez J., Schulte C., Bras J. M., Sharma M., Gibbs J. R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S. W., Hernandez D. G., Kruger R., Federoff M., Klein C., Goate A., Perlmutter J., Bonin M., Nalls M. A., Illig T., Gieger C., Houlden H., Steffens M., Okun M. S., Racette B. A., Cookson M. R., Foote K. D., Fernandez H. H., Traynor B. J., Schreiber S., Arepalli S., Zonozi R., Gwinn K., van der Brug M., Lopez G., Chanock S. J., Schatzkin A., Park Y., Hollenbeck A., Gao J., Huang X., Wood N. W., Lorenz D., Deuschl G., Chen H., Riess O., Hardy J. A., Singleton A. B., Gasser T., Genome-wide association study reveals genetic risk underlying Parkinson's disease Nature Genetics 2009 41 12 1308 1312
9. van Limbergen J., Wilson D. C., Satsangi J., The genetics of Crohn's disease Annual Review of Genomics and Human Genetics 2009 10 89 116
10. Zhang F. R., Huang W., Chen S. M., Sun L. D., Liu H., Li Y., Cui Y., Yan X. X., Yang H. T., Yang R. D., Chu T. S., Zhang C., Zhang L., Han J. W., Yu G. Q., Quan C., Yu Y. X., Zhang Z., Shi B. Q., Zhang L. H., Cheng H., Wang C. Y., Lin Y., Zheng H. F., Fu X. A., Zuo X. B., Wang Q., Long H., Sun Y. P., Cheng Y. L., Tian H. Q., Zhou F. S., Liu H. X., Lu W. S., He S. M., Du W. L., Shen M., Jin Q. Y., Wang Y., Low H. Q., Erwin T., Yang N. H., Li J. Y., Zhao X., Jiao Y. L., Mao L. G., Yin G., Jiang Z. X., Wang X. D., Yu J. P., Hu Z. H., Gong C. H., Liu Y. Q., Liu R. Y., Wang D. M., Wei D., Liu J. X., Cao W. K., Cao H. Z., Li Y. P., Yan W. G., Wei S. Y., Wang K. J., Hibberd M. L., Yang S., Zhang X. J., Liu J. J., Genomewide association study of leprosy New England Journal of Medicine 2009 361 27 2609 2618
11. Liu B., Gao H. M., Hong J. S., Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation Environmental Health Perspectives 2003 111 8 1065 1073 (Pubitemid 36826886)
12. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., Mucke L., Dopaminergic loss and inclusion body formation in -synuclein mice: implications for neurodegenerative disorders Science 2000 287 5456 1265 1269 (Pubitemid 30112148)
13. van der Putten H., Wiederhold K. H., Probst A., Barbieri S., Mistl C., Danner S., Kauffmann S., Hofele K., Spooren W. P. J. M., Ruegg M. A., Lin S., Caroni P., Sommer B., Tolnay M., Bilbe G., Neuropathology in mice expressing human -synuclein The Journal of Neuroscience 2000 20 16 6021 6029 (Pubitemid 30658395)
14. Rockenstein E., Mallory M., Hashimoto M., Song D., Shults C. W., Lang I., Masliah E., Differential neuropathological alterations in transgenic mice expressing -synuclein from the platelet-derived growth factor and Thy-1 promoters Journal of Neuroscience Research 2002 68 5 568 578 (Pubitemid 34575622)
15. Giasson B. I., Duda J. E., Quinn S. M., Zhang B., Trojanowski J. Q., Lee V. M. Y., Neuronal -synucleinopathy with severe movement disorder in mice expressing A53T human -synuclein Neuron 2002 34 4 521 533 (Pubitemid 34628750)
16. Lee M. K., Stirling W., Xu Y., Xu E., Qui D., Mandir A. S., Dawson T. M., Copeland N. G., Jenkins N. A., Price D. L., Human -synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with -synuclein aggregation in transgenic mice Proceedings of the National Academy of Sciences of the United States of America 2002 99 13 8968 8973 (Pubitemid 34693667)
17. Jang A., Lee H. J., Suk J. E., Jung J. W., Kim K. P., Lee S. J., Non-classical exocytosis of -synuclein is sensitive to folding states and promoted under stress conditions Journal of Neurochemistry 2010 113 5 1263 1274
18. Desplats P., Lee H. J., Bae E. J., Patrick C., Rockenstein E., Crews L., Spencer B., Masliah E., Lee S. J., Inclusion formation and neuronal cell death through neuron-to-neuron transmission of -synuclein Proceedings of the National Academy of Sciences of the United States of America 2009 106 31 13010 13015
19. Lee H. J., Suk J. E., Patrick C., Bae E. J., Cho J. H., Rho S., Hwang D., Masliah E., Lee S. J., Direct transfer of -synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies The Journal of Biological Chemistry 2010 285 12 9262 9272
20. Emmanouilidou E., Elenis D., Papasilekas T., Stranjalis G., Gerozissis K., Ioannou P. C., Vekrellis K., Assessment of -synuclein secretion in mouse and human brain parenchyma PLoS One 2011 6 7
21. Wakabayashi K., Hayashi S., Yoshimoto M., Kudo H., Takahashi H., NACP/ -synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains Acta Neuropathologica 2000 99 1 14 20 (Pubitemid 30093433)
22. Benarroch E. E., Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system Mayo Clinic Proceedings 2005 80 10 1326 1338 (Pubitemid 41395966)
23. Gu X. L., Long C. X., Sun L., Xie C., Lin X., Cai H., Astrocytic expression of Parkinson's disease-related A53T -synuclein causes neurodegeneration in mice Molecular Brain 2010 3 1, article 12
24. Semchuk K. M., Love E. J., Lee R. G., Parkinson's disease: a test of the multifactorial etiologic hypothesis Neurology 1993 43 6 1173 1180 (Pubitemid 23177719)
25. Gao H. M., Kotzbauer P. T., Uryu K., Leight S., Trojanowski J. Q., Lee V. M. Y., Neuroinflammation and oxidation/nitration of -synuclein linked to dopaminergic neurodegeneration The Journal of Neuroscience 2008 28 30 7687 7698
26. Gao H. M., Zhang F., Zhou H., Kam W., Wilson B., Hong J. S., Neuroinflammation and -synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease Environmental Health Perspectives 2011 119 6 807 814
27. Jang H., Boltz D., Sturm-Ramirez K., Shepherd K. R., Jiao Y., Webster R., Smeyne R. J., Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration Proceedings of the National Academy of Sciences of the United States of America 2009 106 33 14063 14068
28. Fujita M., Sugama S., Sekiyama K., Sekigawa A., Tsukui T., Nakai M., Waragai M., Takenouchi T., Takamatsu Y., Wei J., Rockenstein E., Laspada A. R., Masliah E., Inoue S., Hashimoto M., A -synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain Nature Communications 2010 1 8, article 110
29. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 1998 392 6676 605 608 (Pubitemid 28207717)
30. Shimura H., Hattori N., Kubo S. I., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T., Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase Nature Genetics 2000 25 3 302 305 (Pubitemid 30437317)
31. Valente E. M., Abou-Sleiman P. M., Caputo V., Muqit M. M. K., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A. R., Healy D. G., Albanese A., Nussbaum R., Gonzalez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W. P., Latchman D. S., Harvey R. J., Dallapiccola B., Auburger G., Wood N. W., Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 2004 304 5674 1158 1160 (Pubitemid 38661852)
32. Youle R. J., Narendra D. P., Mechanisms of mitophagy Nature Reviews Molecular Cell Biology 2011 12 1 9 14
33. Frank-Cannon T. C., Tran T., Ruhn K. A., Martinez T. N., Hong J., Marvin M., Hartley M., Trevino I., O'Brien D. E., Casey B., Goldberg M. S., Tansey M. G., Parkin deficiency increases vulnerability to inflammation-related nigral degeneration The Journal of Neuroscience 2008 28 43 10825 10834
34. Akundi R. S., Huang Z., Eason J., Pandya J. D., Zhi L., Cass W. A., Sullivan P. G., Bueler H., Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in PINK1 -deficient mice PLoS One 2011 6 1
35. Bonifati V., Rizzu P., van Baren M. J., Schaap O., Breedveld G. J., Krieger E., Dekker M. C. J., Squitieri F., Ibanez P., Joosse M., van Dongen J. W., Vanacore N., van Swieten J. C., Brice A., Meco G., van Duijn C. M., Oostra B. A., Heutink P., Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism Science 2003 299 5604 256 259 (Pubitemid 36131051)
36. Annesi G., Savettieri G., Pugliese P., D'Amelio M., Tarantino P., Ragonese P., La Bella V., Piccoli T., Civitelli D., Annesi F., Fierro B., Piccoli F., Arabia G., Caracciolo M., Candiano I. C. C., Quattrone A., DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex Annals of Neurology 2005 58 5 803 807 (Pubitemid 41552561)
37. Bandopadhyay R., Kingsbury A. E., Cookson M. R., Reid A. R., Evans I. M., Hope A. D., Pittman A. M., Lashley T., Canet-Aviles R., Miller D. W., McLendon C., Strand C., Leonard A. J., Abou-Sleiman P. M., Healy D. G., Ariga H., Wood N. W., de Silva R., Revesz T., Hardy J. A., Lees A. J., The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease Brain 2004 127 part 2 420 430 (Pubitemid 38160326)
38. Waak J., Weber S. S., Waldenmaier A., Gorner K., Alunni-Fabbroni M., Schell H., Vogt-Weisenhorn D., Pham T. T., Reumers V., Baekelandt V., Wurst W., Kahle P. J., Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1 The FASEB Journal 2009 23 8 2478 2489
39. Paisan-Ruiz C., Jain S., Evans E. W., Gilks W. P., Simon J., van der Brug M., de Munain A. L., Aparicio S., Gil A. M., Khan N., Johnson J., Martinez J. R., Nicholl D., Carrera I. M., Pena A. S., de Silva R., Lees A., Marti-Masso J. F., Perez-Tur J., Wood N. W., Singleton A. B., Cloning of the gene containing mutations that cause PARK8 -linked Parkinson's disease Neuron 2004 44 4 595 600 (Pubitemid 39531224)
40. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R. J., Calne D. B., Stoessl A. J., Pfeiffer R. F., Patenge N., Carbajal I. C., Vieregge P., Asmus F., Muller-Myhsok B., Dickson D. W., Meitinger T., Strom T. M., Wszolek Z. K., Gasser T., Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 2004 44 4 601 607 (Pubitemid 39531225)
41. Lin X., Parisiadou L., Gu X. L., Wang L., Shim H., Sun L., Xie C., Long C. X., Yang W. J., Ding J., Chen Z. Z., Gallant P. E., Tao-Cheng J. H., Rudow G., Troncoso J. C., Liu Z., Li Z., Cai H., Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease- related mutant -synuclein Neuron 2009 64 6 807 827
42. Tong Y., Pisani A., Martella G., Karouani M., Yamaguchi H., Pothos E. N., Shen J., R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice Proceedings of the National Academy of Sciences of the United States of America 2009 106 34 14622 14627
43. Hashimoto M., Rockenstein E., Mante M., Mallory M., Masliah E., -synuclein inhibits -synuclein aggregation: a possible role as an anti-Parkinsonian factor Neuron 2001 32 2 213 223 (Pubitemid 33030190)
44. Fan Y., Limprasert P., Murray I. V. J., Smith A. C., Lee V. M. Y., Trojanowski J. Q., Sopher B. L., La Spada A. R., -synuclein modulates -synuclein neurotoxicity by reducing -synuclein protein expression Human Molecular Genetics 2006 15 20 3002 3011 (Pubitemid 44530704)
45. Galvin J. E., Uryu K., Lee V. M. Y., Trojanowski J. Q., Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains -, -, and -synuclein Proceedings of the National Academy of Sciences of the United States of America 1999 96 23 13450 13455
46. Galvin J. E., Giasson B., Hurtig H. I., Lee V. M. Y., Trojanowski J. Q., Neurodegeneration with brain iron accumulation, type 1 is characterized by -, -, and -synuclein neuropathology American Journal of Pathology 2000 157 2 361 368 (Pubitemid 30626903)
47. Clayton D. F., George J. M., The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease Trends in Neurosciences 1998 21 6 249 254 (Pubitemid 28239982)
48. Ohtake H., Limprasert P., Fan Y., Onodera O., Kakita A., Takahashi H., Bonner L. T., Tsuang D. W., Murray I. V. J., Lee V. M. Y., Trojanowski J. Q., Ishikawa A., Idezuka J., Murata M., Toda T., Bird T. D., Leverenz J. B., Tsuji S., La Spada A. R., -synuclein gene alterations in dementia with Lewy bodies Neurology 2004 63 5 805 811 (Pubitemid 39297638)
49. Wei J., Fujita M., Nakai M., Waragai M., Watabe K., Akatsu H., Rockenstein E., Masliah E., Hashimoto M., Enhanced lysosomal pathology caused by -synuclein mutants linked to dementia with Lewy bodies The Journal of Biological Chemistry 2007 282 39 28904 28914 (Pubitemid 47606052)
50. Wei J., Fujita M., Nakai M., Waragai M., Sekigawa A., Sugama S., Takenouchi T., Masliah E., Hashimoto M., Protective role of endogenous gangliosides for lysosomal pathology in a cellular model of synucleinopathies American Journal of Pathology 2009 174 5 1891 1909
51. Ninkina N., Peters O., Millership S., Salem H., van der Putten H., Buchman V. L., -Synucleinopathy: neurodegeneration associated with overexpression of the mouse protein Human Molecular Genetics 2009 18 10 1779 1794
52. Yazawa I., Giasson B. I., Sasaki R., Zhang B., Joyce S., Uryu K., Trojanowski J. Q., Lee V. M. Y., Mouse model of multiple system atrophy -synuclein expression in oligodendrocytes causes glial and neuronal degeneration Neuron 2005 45 6 847 859 (Pubitemid 40395264)
53. Shults C. W., Rockenstein E., Crews L., Adame A., Mante M., Larrea G., Hashimoto M., Song D., Iwatsubo T., Tsuboi K., Masliah E., Neurological and neurodegenerative alterations in a transgenic mouse model expressing human -synuclein under oligodendrocyte promoter: implications for multiple system atrophy The Journal of Neuroscience 2005 25 46 10689 10699 (Pubitemid 41681917)
54. Kahle P. J., Neumann M., Ozmen L., Muller V., Jacobsen H., Spooren W., Fuss B., Mallon B., Macklin W. B., Fujiwara H., Hasegawa M., Iwatsubo T., Kretzschmar H. A., Haass C., Hyperphosphorylation and insolubility of -synuclein in transgenic mouse oligodendrocytes EMBO Reports 2002 3 6 583 588 (Pubitemid 34752460)
55. Simons M., Trajkovic K., Neuron-glia communication in the control of oligodencrocyte function and myelin biogenesis Journal of Cell Science 2006 119 part 21 4381 4389 (Pubitemid 44830637)
56. deSilva T. M., Kabakov A. Y., Goldhoff P. E., Volpe J. J., Rosenberg P. A., Regulation of glutamate transport in developing rat oligodendrocytes The Journal of Neuroscience 2009 29 24 7898 7908
57. Stefanova N., Fellner L., Reindl M., Masliah E., Poewe W., Wenning G. K., Toll-like receptor 4 promotes -synuclein clearance and survival of nigral dopaminergic neurons American Journal of Pathology 2011 179 2 954 963